Biopharmaceutical
United
Kingdom
States
Cancer
Therapies
Development
Acquire
M&A Advisory
Lazard
Full Credential Description
Sierra Oncology. United Kingdom, United States. Announced Date 13/04/2022. Closed Date 01/07/2022. Deal value: $1900m. GSK to acquire Sierra Oncology. Industry: Sierra Oncology is a biopharmaceutical company focused on developing targeted therapies for the treatment of cancer.